Competitor Landscape: Spondyloarthritis

2018-11-30
Competitor Landscape: Spondyloarthritis Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the spondyloarthritis (SpA) market, analysis of current & potential future...

Multiple Sclerosis: Dynamic Market Forecast to 2026

2018-11-30
Multiple Sclerosis: Dynamic Market Forecast to 2026 Summary Multiple Sclerosis (MS) is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients...

Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)

2018-11-30
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH) Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the NASH market, analysis of current & potential future...

Competitor Landscape: Graft Versus Host Disease (GVHD)

2018-11-30
Competitor Landscape: Graft Versus Host Disease (GVHD) Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the graft versus host disease (GVHD) market, analysis of current...

Competitor Landscape: Systemic Sclerosis (Scleroderma)

2018-11-30
Competitor Landscape: Systemic Sclerosis (Scleroderma) Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Systemic Sclerosis (Scleroderma) market, analysis of current...

Atopic Dermatitis: Epidemiology Forecast to 2027

2018-11-27
Atopic Dermatitis: Epidemiology Forecast to 2027 Summary Atopic dermatitis (AD) or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Although the condition affects people of all ages, it is...

Malaria: Epidemiology Forecast to 2027

2018-11-27
Malaria: Epidemiology Forecast to 2027 Summary Malaria is a vector-borne disease caused by parasites of the genus Plasmodium. Malaria is transmitted through the bite of the female Anopheles mosquito. Upon infecting a new human host, parasites...

Pompe Disease: Epidemiology Forecast to 2027

2018-11-27
Pompe Disease: Epidemiology Forecast to 2027 Summary Pompe disease is a rare multisystem disorder caused by pathogenic variations in the GAA gene, which contains the information for production and function of a protein called acid alpha-glucosidase...

Pompe Disease: Opportunity Analysis and Forecasts to 2027

2018-11-27
Pompe Disease: Opportunity Analysis and Forecasts to 2027 Summary Pompe disease (PD) is a rare genetic disorder resulting in the accumulation of glycogen with lysosomes in various tissues of the body. It is caused by a multitude of different...

Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027

2018-11-24
Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027 Summary Atopic Dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages and is the result of a complex interplay of environmental,...
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy